Tudor Investment Corp ET AL trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 38.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 175,344 shares of the company’s stock after selling 108,724 shares during the quarter. Tudor Investment Corp ET AL owned approximately 0.11% of Option Care Health worth $4,868,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada boosted its position in shares of Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after acquiring an additional 39,661 shares during the last quarter. AQR Capital Management LLC increased its stake in Option Care Health by 162.6% in the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after purchasing an additional 25,777 shares during the period. Empowered Funds LLC purchased a new stake in Option Care Health in the first quarter worth $208,000. Invesco Ltd. increased its stake in Option Care Health by 2.7% in the second quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after purchasing an additional 7,678 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in Option Care Health by 528.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after purchasing an additional 1,183 shares during the period. 98.05% of the stock is currently owned by institutional investors.
Option Care Health Stock Performance
Shares of Option Care Health stock opened at $29.16 on Thursday. The firm has a market cap of $4.56 billion, a P/E ratio of 22.78, a P/E/G ratio of 1.54 and a beta of 0.95. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 0.87. Option Care Health, Inc. has a 12 month low of $24.24 and a 12 month high of $36.80. The stock’s fifty day moving average price is $31.26 and its 200-day moving average price is $30.66.
Analyst Ratings Changes
A number of research firms have weighed in on OPCH. Truist Financial set a $40.00 target price on Option Care Health in a research note on Tuesday, January 13th. Citizens Jmp reiterated a “market outperform” rating and issued a $38.00 target price (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. Morgan Stanley increased their target price on Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. Barrington Research increased their target price on Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $37.27.
Check Out Our Latest Stock Report on OPCH
Option Care Health Company Profile
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
See Also
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
